Altium Capital Management
Latest statistics and disclosures from Altium Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are VERA, ADMA, SRPT, EW, XENE, and represent 31.75% of Altium Capital Management's stock portfolio.
- Added to shares of these 10 stocks: EW (+$15M), SRPT (+$11M), GKOS (+$10M), MMSI (+$8.4M), PCVX (+$8.2M), ARWR (+$6.9M), IRTC (+$6.4M), EOLS (+$5.8M), ESTA (+$5.7M), RXST (+$5.5M).
- Started 32 new stock positions in NKTR, CYBN, UNCY, BTTR, ARWR, APLT, EW, GPCR, OCGN, CTMX.
- Reduced shares in these 10 stocks: Alimera Sciences (-$12M), ARGX (-$9.9M), ASND (-$6.8M), INSM, MLTX, Cybin Ord, ADMA, RARE, ITCI, CPRX.
- Sold out of its positions in ACHV, Alimera Sciences, ALUR, APDN, APRE, ARGX, ASND, Biovie, BOLD, CETX. CNTX, Cybin Ord, Evoke Pharma, INBS, LXRX, PMNT, QNRX, RAPT, SPRB, RARE, SLNWF.
- Altium Capital Management was a net buyer of stock by $70M.
- Altium Capital Management has $340M in assets under management (AUM), dropping by 38.59%.
- Central Index Key (CIK): 0001746382
Tip: Access up to 7 years of quarterly data
Positions held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv

Portfolio Holdings for Altium Capital Management
Altium Capital Management holds 77 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Vera Therapeutics Cl A (VERA) | 8.9 | $30M | -4% | 684k | 44.20 |
|
Adma Biologics (ADMA) | 8.0 | $27M | -9% | 1.4M | 19.99 |
|
Sarepta Therapeutics (SRPT) | 6.2 | $21M | +107% | 170k | 124.89 |
|
Edwards Lifesciences (EW) | 4.3 | $15M | NEW | 222k | 65.99 |
|
Xenon Pharmaceuticals (XENE) | 4.3 | $15M | +2% | 370k | 39.37 |
|
Zevra Therapeutics Com New (ZVRA) | 3.5 | $12M | +46% | 1.7M | 6.94 |
|
Intra Cellular Therapies (ITCI) | 3.3 | $11M | -20% | 154k | 73.17 |
|
Soleno Therapeutics (SLNO) | 3.2 | $11M | 213k | 50.49 |
|
|
Glaukos (GKOS) | 3.0 | $10M | NEW | 77k | 130.28 |
|
Insmed Com Par $.01 (INSM) | 2.8 | $9.5M | -31% | 130k | 73.00 |
|
Merit Medical Systems (MMSI) | 2.5 | $8.4M | NEW | 85k | 98.83 |
|
Rezolute Com New (RZLT) | 2.4 | $8.2M | 1.7M | 4.85 |
|
|
Vaxcyte (PCVX) | 2.4 | $8.2M | NEW | 72k | 114.27 |
|
Avadel Pharmaceuticals Com Shs (AVDL) | 2.4 | $8.0M | 610k | 13.12 |
|
|
Viking Therapeutics (VKTX) | 2.3 | $8.0M | +3% | 126k | 63.31 |
|
Catalyst Pharmaceutical Partners (CPRX) | 2.3 | $7.7M | -23% | 385k | 19.88 |
|
Contineum Therapeutics Cl A (CTNM) | 2.1 | $7.1M | -14% | 369k | 19.14 |
|
Arrowhead Pharmaceuticals (ARWR) | 2.0 | $6.9M | NEW | 355k | 19.37 |
|
Savara (SVRA) | 2.0 | $6.7M | 1.6M | 4.24 |
|
|
Irhythm Technologies (IRTC) | 1.9 | $6.4M | NEW | 86k | 74.24 |
|
Larimar Therapeutics (LRMR) | 1.7 | $5.8M | 889k | 6.55 |
|
|
Evolus (EOLS) | 1.7 | $5.8M | NEW | 355k | 16.20 |
|
Establishment Labs Holdings Ord (ESTA) | 1.7 | $5.7M | NEW | 131k | 43.27 |
|
Rxsight (RXST) | 1.6 | $5.5M | NEW | 112k | 49.43 |
|
Axsome Therapeutics (AXSM) | 1.5 | $5.2M | +16% | 58k | 89.87 |
|
Skye Bioscience Com New (SKYE) | 1.5 | $5.1M | -2% | 1.3M | 3.91 |
|
Xtant Med Hldgs Com New (XTNT) | 1.5 | $5.0M | 7.4M | 0.68 |
|
|
Capricor Therapeutics Com New (CAPR) | 1.3 | $4.3M | NEW | 285k | 15.21 |
|
Pulmonx Corp (LUNG) | 1.2 | $4.1M | NEW | 500k | 8.29 |
|
Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.2 | $4.0M | NEW | 195k | 20.63 |
|
Keros Therapeutics (KROS) | 1.2 | $4.0M | NEW | 69k | 58.07 |
|
Realreal (REAL) | 1.2 | $4.0M | 1.3M | 3.14 |
|
|
Perspective Therapeutics Com New (CATX) | 1.1 | $3.9M | +51% | 290k | 13.35 |
|
Biohaven (BHVN) | 1.1 | $3.7M | NEW | 75k | 49.97 |
|
Oric Pharmaceuticals (ORIC) | 1.1 | $3.6M | -12% | 355k | 10.25 |
|
Structure Therapeutics Sponsored Ads (GPCR) | 0.9 | $3.1M | NEW | 70k | 43.89 |
|
Outlook Therapeutics (OTLK) | 0.9 | $2.9M | +7% | 542k | 5.34 |
|
Vericel (VCEL) | 0.8 | $2.9M | NEW | 68k | 42.25 |
|
Cybin Com New (CYBN) | 0.8 | $2.8M | NEW | 317k | 8.89 |
|
Terns Pharmaceuticals (TERN) | 0.8 | $2.8M | NEW | 330k | 8.34 |
|
Ocugen (OCGN) | 0.7 | $2.3M | NEW | 2.4M | 0.99 |
|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.6 | $2.0M | -65% | 40k | 50.42 |
|
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.6 | $1.9M | NEW | 85k | 22.63 |
|
Annovis Bio Put Option (ANVS) | 0.6 | $1.9M | +52% | 236k | 8.06 |
|
Female Health (VERU) | 0.5 | $1.6M | -10% | 2.0M | 0.77 |
|
AtriCure (ATRC) | 0.4 | $1.5M | NEW | 54k | 28.04 |
|
Cytomx Therapeutics (CTMX) | 0.3 | $1.1M | NEW | 915k | 1.18 |
|
Envveno Medical (NVNO) | 0.2 | $803k | NEW | 239k | 3.36 |
|
Tempest Therapeutics (TPST) | 0.2 | $763k | NEW | 545k | 1.40 |
|
Promis Neurosciences Com New (PMN) | 0.2 | $727k | NEW | 581k | 1.25 |
|
Milestone Pharmaceuticals (MIST) | 0.2 | $669k | -56% | 440k | 1.52 |
|
Karyopharm Therapeutics (KPTI) | 0.2 | $614k | 740k | 0.83 |
|
|
Unicycive Therapeutics (UNCY) | 0.2 | $601k | NEW | 1.5M | 0.41 |
|
Fat Brands *w Exp 07/16/202 (FATBW) | 0.1 | $499k | 200k | 2.50 |
|
|
Applied Therapeutics Put Option (APLT) | 0.1 | $477k | NEW | 56k | 8.50 |
|
Cellectar Biosciences Com New (CLRB) | 0.1 | $460k | NEW | 215k | 2.14 |
|
Better Choice Com New (BTTR) | 0.1 | $278k | NEW | 133k | 2.09 |
|
Expion360 (XPON) | 0.0 | $106k | NEW | 2.1M | 0.05 |
|
Nexgel *w Exp 12/01/202 (NXGLW) | 0.0 | $92k | 225k | 0.41 |
|
|
Scorpius Holdings (SCPX) | 0.0 | $64k | NEW | 88k | 0.72 |
|
Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $51k | 732k | 0.07 |
|
|
Onfolio Holdings *w Exp 01/02/202 (ONFOW) | 0.0 | $34k | 200k | 0.17 |
|
|
Wearable Devices *w Exp 09/14/202 (WLDSW) | 0.0 | $28k | 1.4M | 0.02 |
|
|
Mobix Labs *w Exp 99/99/999 (MOBXW) | 0.0 | $22k | 150k | 0.15 |
|
|
Cingulate *w Exp 12/10/202 (CINGW) | 0.0 | $19k | 270k | 0.07 |
|
|
Nektar Therapeutics (NKTR) | 0.0 | $15k | NEW | 11k | 1.30 |
|
Nexalin Technology *w Exp 99/99/999 (NXLIW) | 0.0 | $8.4k | 105k | 0.08 |
|
|
Cea Industries *w Exp 02/11/202 (CEADW) | 0.0 | $6.3k | 250k | 0.03 |
|
|
Vsee Health *w Exp 99/99/999 (VSEEW) | 0.0 | $6.0k | 150k | 0.04 |
|
|
Bitcoin Depot *w Exp 06/30/202 (BTMWW) | 0.0 | $2.5k | 50k | 0.05 |
|
|
Jeffs Brands *w Exp 99/99/999 (JFBRW) | 0.0 | $2.4k | 69k | 0.04 |
|
|
Nls Pharmaceutics *w Exp 02/02/202 (NLSPW) | 0.0 | $2.3k | 200k | 0.01 |
|
|
Western Acqstn Ventures Corp *w Exp 99/99/999 (WAVSW) | 0.0 | $2.2k | 100k | 0.02 |
|
|
Conduit Pharmaceuticals *w Exp 09/22/202 (CDTTW) | 0.0 | $1.6k | 100k | 0.02 |
|
|
Coliseum Acquisition Corp *w Exp 08/22/202 (MITAW) | 0.0 | $1.4k | 28k | 0.05 |
|
|
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.0k | 82k | 0.01 |
|
|
Tc Biopharm Holdings *w Exp 02/10/202 (TCBPW) | 0.0 | $342.578600 | 19k | 0.02 |
|
Past Filings by Altium Capital Management
SEC 13F filings are viewable for Altium Capital Management going back to 2020
- Altium Capital Management 2024 Q3 filed Nov. 14, 2024
- Altium Capital Management 2024 Q2 filed Aug. 15, 2024
- Altium Capital Management 2024 Q1 filed May 15, 2024
- Altium Capital Management 2023 Q3 filed Nov. 14, 2023
- Altium Capital Management 2023 Q2 filed Aug. 14, 2023
- Altium Capital Management 2023 Q1 filed May 15, 2023
- Altium Capital Management 2022 Q4 filed Feb. 14, 2023
- Altium Capital Management 2022 Q3 filed Nov. 14, 2022
- Altium Capital Management 2022 Q2 filed Aug. 15, 2022
- Altium Capital Management 2022 Q1 filed May 16, 2022
- Altium Capital Management 2021 Q4 filed Feb. 14, 2022
- Altium Capital Management 2021 Q3 restated filed Nov. 17, 2021
- Altium Capital Management 2021 Q3 filed Nov. 15, 2021
- Altium Capital Management 2021 Q2 filed Aug. 13, 2021
- Altium Capital Management 2021 Q1 filed May 6, 2021
- Altium Capital Management 2020 Q4 restated filed May 5, 2021